Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.

Journal of gastroenterology and hepatology - 1 Feb 2011

Park Kyung Sook, Kim Seon Jeong, Kim Kyung Ho, Kim Jin Cheon

Abstract excerpt

BACKGROUND AND AIM: Genetic variations and the expression profile of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) are involved in the invasion and metastasis of colorectal cancer. METHODS: The gene profiles of TIMP2 and MMP were assayed from 333 colorectal cancer using polymerase chain reaction-restriction fragment length polymorphism. RESULTS: TIMP2-418*G/*G, TIMP2 303*G/*G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Matrix Metalloproteinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Matrix Metalloproteinase 9

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Republic of Korea

Share to Risk Assessment

Share to Tissue Inhibitor of Metalloproteinase-2

Source

Identifiers

PMID: 21261731
DOI: 10.1111/j.1440-1746.2010.06504.x

Genes

TIMP2
MMP2
MMP9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.PMID 21261731Read ↗

MMP-2, -3 and TIMP-2, -3 polymorphisms in colorectal cancer in a Chinese Han population: A case-control study.Semantic proximity Read ↗

Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients.Semantic proximity Read ↗

Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer.Semantic proximity Read ↗

No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis.Semantic proximity Read ↗

Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.Semantic proximity Read ↗

Matrix metalloproteinase 9 -1562C/T polymorphism increased protein levels in patients with colorectal cancer in a sample from southeastern Brazil.Semantic proximity Read ↗

A Comprehensive Bioinformatics Analysis of TIMP2 in Multiple MalignanciesSemantic proximity Read ↗

Association of TIMP2 418 G/C and MMP Gene Polymorphism with Risk of Urinary Cancers: Systematic Review and Meta-analysis.Semantic proximity Read ↗

Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese.Semantic proximity Read ↗

Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.Semantic proximity Read ↗

rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.Semantic proximity Read ↗

TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.